The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...
Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal. MiroBio was formed in 2019 to ...
Four years after Bristol-Myers Squibb paid $1.85 billion upfront to make Nektar's bempegaldesleukin a companion drug to its cancer immunotherapy Opdivo, the alliance is being discontinued.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果